2Emmanuel L. Bravo MD. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease[J] 2003,Current Hypertension Reports(2):122～125
3Mario Fritsch Neves MD,Ernesto L. Schiffrin MD, PhD, FRCPC. Aldosterone: A risk factor for vascular disease[J] 2003,Current Hypertension Reports(1):59～65
2Theeuwes F. Elementary osmotic pump[J]. Pharm Sci, 1975, 64(12):1 987.
3Santus G, Baker RW. Osmotic drug delivery: a review of the oatent literature[J]. Control Release. 1995,35 (1) : 1.
4Verma RK, Arora S ,Garg S.Osmotic pumps in drug delivery[J]. Crit Rev Ther Drug Carr Syst , 2004,21 (6) : 477.
5Billon A, Bataille B, Cassanas G, et al. Development of spray-dried acetaminophen microparticlesusing experimental designs[J]. International Journal of Pharmaeeutics, 2000,203 (1-2) : 159.
6Eddy CG, Antonio IC, Bernard B, et al. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride[J]. International Journal ofPharmaceutics, 2006,317 ( 1 ) : 32.
7Nazzal S, Nutan M, Palamakula A, et al. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients [J]. International Journal of Pharmaceutics, 2002,240 ( 1-2 ) : 103.
